Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2021 | Cyteir Therapeutics | $80.0M Series C | Derek DiRocco | Advanced Technology Ventures, Aisling Capital, Dolby Family Ventures, Novo Ventures, RA Capital, Venrock, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, CaaS Capital Management, Droia Ventures, Janus Henderson Investors, Lightstone Ventures, Osage University Partners |
| Jul 5, 2020 | Freeline | $120.0M Series C Extension | Eventide Asset Management, Thomas Dyrberg, Wellington Management | Acorn Bioventures, Cowen Healthcare Investments |